報價延遲最少15分鐘:2026/05/16 16:47 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.97 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.43/0.53
|
|
企業價值
162.23M
|
| 資產負債 |
|
每股賬面淨值
-1.85
|
| 現金流量 |
|
現金流量率
0.46
|
| 損益表 |
|
收益
192.22M
|
|
每股收益
5.95
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements. |
